Conduction abnormalities and ventricular arrhythmogenesis: The roles of sodium channels and gap junctions

IJC Heart and Vasculature

Volumn 9, Issue , 2015, Pages 75-82

  Tse, Gary ^a   Yeo, Jie Ming ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Conduction; Conduction velocity; Gap junction; Sodium channel; Ventricular arrhythmia

Indexed keywords

SODIUM CHANNEL;

ACTION POTENTIAL; ARRHYTHMOGENESIS; GAP JUNCTION; GENE MUTATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; INFARCTION; ISCHEMIA; LONG QT SYNDROME 3; MEMBRANE CURRENT; MUSCLE CELL; NERVE BLOCK; NERVE CONDUCTION VELOCITY; NONHUMAN; OCULODENTODIGITAL SYNDROME; PROGRESSIVE CARDIAC CONDUCTION DEFECT; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SICK SINUS SYNDROME;

EID: 84946014380     PISSN: 23529067     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcha.2015.10.003     Document Type: Review

References (194)

1. Adabag A.S., Luepker R.V., Roger V.L., Gersh B.J. Sudden cardiac death: epidemiology and risk factors. Nat. Rev. Cardiol. 2010, 7:216-225.
2. Zheng Z.J., Croft J.B., Giles W.H., Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001, 104:2158-2163.
3. Zipes D.P., Wellens H.J. Sudden cardiac death. Circulation 1998, 98:2334-2351.
4. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. J. Am. Med. Assoc. 2001, 285:2370-2375.
5. Blackshear J.L., Kopecky S.L., Litin S.C., Safford R.E., Hammill S.C. Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment. Mayo Clin. Proc. 1996, 71:150-160.
6. Rockson S.G., Albers G.W. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J. Am. Coll. Cardiol. 2004, 43:929-935.
7. Marcus F.I. Depolarization/repolarization, electrocardiographic abnormalities, and arrhythmias in cardiac channelopathies. J. Electrocardiol. 2005, 38:60-63.
8. Kléber A.G., Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol. Rev. 2004, 84:431-488.
9. Moe G.K. Evidence for reentry as a mechanism of cardiac arrhythmias. Rev. Physiol. Biochem. Pharmacol. 1975, 72:55-81.
10. Janse M.J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 1989, 69:1049-1169.
11. Mines G.R. On dynamic equilibrium in the heart. J. Physiol. 1913, 46:349-383.
12. Allessie M.A., Bonke F.I., Schopman F.J. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. Circ. Res. 1973, 33:54-62.
13. Krishnan S.C., Antzelevitch C. Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry?. Circulation 1993, 87:562-572.
14. Antzelevitch C., Jalife J., Moe G.K. Characteristics of reflection as a mechanism of reentrant arrhythmias and its relationship to parasystole. Circulation 1980, 61:182-191.
15. Veeraraghavan R., Gourdie R.G., Poelzing S. Mechanisms of cardiac conduction: a history of revisions. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H619-H627.
16. Shaw R.M., Rudy Y. Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ. Res. 1997, 81:727-741.
17. Hodgkin A.L., Katz B. The effect of sodium ions on the electrical activity of giant axon of the squid. J. Physiol. 1949, 108:37-77.
18. Brismar T. Slow mechanism for sodium permeability inactivation in myelinated nerve fibre of Xenopus laevis. J. Physiol. 1977, 270:283-297.
19. Ruff R.L., Simoncini L., Stuhmer W. Comparison between slow sodium channel inactivation in rat slow- and fast-twitch muscle. J. Physiol. 1987, 383:339-348.
20. Furue T., Yakehiro M., Yamaoka K., Sumii K., Seyama I. Characteristics of two slow inactivation mechanisms and their influence on the sodium channel activity of frog ventricular myocytes. Pflugers Arch. 1998, 436:631-638.
21. Simoncini L., Stuhmer W. Slow sodium channel inactivation in rat fast-twitch muscle. J. Physiol. 1987, 383:327-337.
22. Ruff R.L., Simoncini L., Stuhmer W. Slow sodium channel inactivation in mammalian muscle: a possible role in regulating excitability. Muscle Nerve 1988, 11:502-510.
23. Kootsey J.M. Electrical propagation in distributed cardiac tissue. Theory of Heart: Biomechanics, Biophysics, and Nonlinear Dynamics of Cardiac Function 1991, 391-403. Springer-Verlag, New York. L. Glass, P. Hunter, A.D. McCulloch (Eds.).
24. Thomas S.P., Kucera J.P., Bircher-Lehmann L., Rudy Y., Saffitz J.E., Kleber A.G. Impulse propagation in synthetic strands of neonatal cardiac myocytes with genetically reduced levels of connexin43. Circ. Res. 2003, 92:1209-1216.
25. Rohr S., Kucera J.P., Kleber A.G. Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ. Res. 1998, 83:781-794.
26. Weidmann S. The electrical constants of Purkinje fibres. J. Physiol. 1952, 118:348-360.
27. Veeraraghavan R., Salama M.E., Poelzing S. Interstitial volume modulates the conduction velocity-gap junction relationship. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H278-H286.
28. Spach M.S., Heidlage J.F., Barr R.C., Dolber P.C. Cell size and communication: role in structural and electrical development and remodeling of the heart. Heart Rhythm. 2004, 1:500-515.
29. Dhein S., Seidel T., Salameh A., Jozwiak J., Hagen A., Kostelka M., et al. Remodeling of cardiac passive electrical properties and susceptibility to ventricular and atrial arrhythmias. Front. Physiol. 2014, 5:424.
30. Lin J., Keener J.P. Ephaptic coupling in cardiac myocytes. IEEE Trans. Biomed. Eng. 2013, 60:576-582.
31. Rohr S. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc. Res. 2004, 62:309-322.
32. Saffitz J.E., Kanter H.L., Green K.G., Tolley T.K., Beyer E.C. Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ. Res. 1994, 74:1065-1070.
33. Spach M.S. Transition from a continuous to discontinuous understanding of cardiac conduction. Circ. Res. 2003, 92:125-126.
34. Spach M.S., Miller W.T., Geselowitz D.B., Barr R.C., Kootsey J.M., Johnson E.A. The discontinuous nature of propagation in normal canine cardiac muscle. Evidence for recurrent discontinuities of intracellular resistance that affect the membrane currents. Circ. Res. 1981, 48:39-54.
35. Sano T., Takayama N., Shimamoto T. Directional difference of conduction velocity in the cardiac ventricular syncytium studied by microelectrodes. Circ. Res. 1959, 7:262-267.
36. Clerc L. Directional differences of impulse spread in trabecular muscle from mammalian heart. J. Physiol. 1976, 255:335-346.
37. Kumar N.M., Gilula N.B. The gap junction communication channel. Cell 1996, 84:381-388.
38. Romero L., Trenor B., Ferrero J.M., Starmer C.F. Non-uniform dispersion of the source-sink relationship alters wavefront curvature. PLoS One 2013, 8.
39. Huelsing D.J., Pollard A.E., Spitzer K.W. Transient outward current modulates discontinuous conduction in rabbit ventricular cell pairs. Cardiovasc. Res. 2001, 49:779-789.
40. Spitzer K.W., Pollard A.E., Yang L., Zaniboni M., Cordeiro J.M., Huelsing D.J. Cell-to-cell electrical interactions during early and late repolarization. J. Cardiovasc. Electrophysiol. 2006, 17(Suppl. 1):S8-S14.
41. Cohen S.A. Immunocytochemical localization of rH1 sodium channel in adult rat heart atria and ventricle. Presence in terminal intercalated disks. Circulation 1996, 94:3083-3086.
42. Kucera J.P., Rohr S., Rudy Y. Localization of sodium channels in intercalated disks modulates cardiac conduction. Circ. Res. 2002, 91:1176-1182.
43. Veeraraghavan R., Lin J., Hoeker G.S., Keener J.P., Gourdie R.G., Poelzing S. Sodium channels in the Cx43 gap junction perinexus may constitute a cardiac ephapse: an experimental and modeling study. Pflugers Arch. 2015, 467:2093-2105.
44. Cerrone M., Delmar M. Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome. Trends Cardiovasc. Med. 2014, 24:184-190.
45. Veeraraghavan R., Poelzing S., Gourdie R.G. Old cogs, new tricks: a scaffolding role for connexin43 and a junctional role for sodium channels?. FEBS Lett. 2014, 588:1244-1248.
46. Shaw R.M., Rudy Y. The vulnerable window for unidirectional block in cardiac tissue: characterization and dependence on membrane excitability and intercellular coupling. J. Cardiovasc. Electrophysiol. 1995, 6:115-131.
47. Coronel R. Heterogeneity in extracellular potassium concentration during early myocardial ischaemia and reperfusion: implications for arrhythmogenesis. Cardiovasc. Res. 1994, 28:770-777.
48. Kodama I., Wilde A., Janse M.J., Durrer D., Yamada K. Combined effects of hypoxia, hyperkalemia and acidosis on membrane action potential and excitability of guinea-pig ventricular muscle. J. Mol. Cell. Cardiol. 1984, 16:247-259.
49. Gellens M.E., George A.L.J., Chen L.Q., Chahine M., Horn R., Barchi R.L., et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:554-558.
50. Stuhmer W., Conti F., Suzuki H., Wang X.D., Noda M., Yahagi N., et al. Structural parts involved in activation and inactivation of the sodium channel. Nature 1989, 339:597-603.
51. Kontis K.J., Rounaghi A., Goldin A.L. Sodium channel activation gating is affected by substitutions of voltage sensor positive charges in all four domains. J. Gen. Physiol. 1997, 110:391-401.
52. Horn R., Patlak J., Stevens C.F. Sodium channels need not open before they inactivate. Nature 1981, 291:426-427.
53. West J.W., Patton D.E., Scheuer T., Wang Y., Goldin A.L., Catterall W.A. A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10910-10914.
54. + channel inactivation gate during inactivation. J. Biol. Chem. 1996, 271:30971-30979.
55. + channels. J. Gen. Physiol. 1997, 109:607-617.
56. + channels. J. Gen. Physiol. 1997, 109:589-605.
57. Smith M.R., Goldin A.L. Interaction between the sodium channel inactivation linker and domain III S4-S5. Biophys. J. 1997, 73:1885-1895.
58. Balser J.R., Nuss H.B., Chiamvimonvat N., Perez-Garcia M.T., Marban E., Tomaselli G.F. External pore residue mediates slow inactivation in mu 1 rat skeletal muscle sodium channels. J. Physiol. 1996, 494(Pt 2):431-442.
59. Vilin Y.Y., Makita N., George A.L., Ruben P.C. Structural determinants of slow inactivation in human cardiac and skeletal muscle sodium channels. Biophys. J. 1999, 77:1384-1393.
60. Gintant G.A., Datyner N.B., Cohen I.S. Slow inactivation of a tetrodotoxin-sensitive current in canine cardiac Purkinje fibers. Biophys. J. 1984, 45:509-512.
61. Carmeliet E. Slow inactivation of the sodium current in rabbit cardiac Purkinje fibres. Pflugers Arch. 1987, 408:18-26.
62. Patlak J.B., Ortiz M. Slow currents through single sodium channels of the adult rat heart. J. Gen. Physiol. 1985, 86:89-104.
63. Kiyosue T., Arita M. Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes. Circ. Res. 1989, 64:389-397.
64. Wingo T.L., Shah V.N., Anderson M.E., Lybrand T.P., Chazin W.J., Balser J.R. An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability. Nat. Struct. Mol. Biol. 2004, 11:219-225.
65. 2+-sensitivity?. Biochemistry 2000, 39:1316-1323.
66. Van Petegem F., Lobo P.A., Ahern C.A. Seeing the forest through the trees: towards a unified view on physiological calcium regulation of voltage-gated sodium channels. Biophys. J. 2012, 103:2243-2251.
67. + channel function, regulation, structure, trafficking and sequestration. J. Physiol. 2015, 593:1347-1360.
68. + channels. J. Clin. Investig. 2006, 116:3127-3138.
69. Dudel J., Peper K., Rudel R., Trautwein W. Effect of tetrodotoxin on membrane currents in mammalian cardiac fibres. Nature 1967, 213:296-297.
70. Satin J., Kyle J.W., Chen M., Bell P., Cribbs L.L., Fozzard H.A., et al. A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties. Science 1992, 256:1202-1205.
71. Sangameswaran L., Fish L.M., Koch B.D., Rabert D.K., Delgado S.G., Ilnicka M., et al. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J. Biol. Chem. 1997, 272:14805-14809.
72. Tzoumaka E., Tischler A.C., Sangameswaran L., Eglen R.M., Hunter J.C., Novakovic S.D. Differential distribution of the tetrodotoxin-sensitive rPN4/NaCh6/Scn8a sodium channel in the nervous system. J. Neurosci. Res. 2000, 60:37-44.
73. Klugbauer N., Lacinova L., Flockerzi V., Hofmann F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J. 1995, 14:1084-1090.
74. Na is greater in dog heart Purkinje fibers than in ventricles. Cardiovasc. Res. 2005, 65:117-127.
75. Lei M., Jones S.A., Liu J., Lancaster M.K., Fung S.S., Dobrzynski H., et al. Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking. J. Physiol. 2004, 559:835-848.
76. Maier S.K., Westenbroek R.E., Schenkman K.A., Feigl E.O., Scheuer T., Catterall W.A. An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4073-4078.
77. Brette F., Orchard C.H. No apparent requirement for neuronal sodium channels in excitation-contraction coupling in rat ventricular myocytes. Circ. Res. 2006, 98:667-674.
78. Marban E. Cardiac channelopathies. Nature 2002, 415:213-218.
79. Wang Q., Shen J., Li Z., Timothy K., Vincent G.M., Priori S.G., et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum. Mol. Genet. 1995, 4:1603-1607.
80. Bennett P.B., Yazawa K., Makita N., George A.L. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995, 376:683-685.
81. + channel mutations in the congenital long QT syndrome. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:13200-13205.
82. + channel-linked long-QT syndrome. Circ. Res. 1996, 78:916-924.
83. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol. Rev. 1999, 79:917-1017.
84. 2+ current. Circ. Res. 1989, 64:977-990.
85. 2+ exchange current in Cs(+)-induced early afterdepolarizations in Purkinje fibers. J. Cardiovasc. Electrophysiol. 1994, 5:933-944.
86. Liu M.B., de Lange E., Garfinkel A., Weiss J.N., Qu Z. Delayed afterdepolarizations generate both triggers and a vulnerable substrate promoting reentry in cardiac tissue. Heart Rhythm. 2015.
87. + current: potential mechanism for sudden death in epilepsy. Circ Arrhythm Electrophysiol. 2015, 8:912-920.
88. George A.L. Misplaced brain sodium channels in heart kindle sudden death in epilepsy. Circ. Arrhythm. Electrophysiol. 2015, 8:769-771.
89. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998, 392:293-296.
90. Veldkamp M.W., Viswanathan P.C., Bezzina C., Baartscheer A., Wilde A.A., Balser J.R. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ. Res. 2000, 86:E91-E97.
91. Litovsky S.H., Antzelevitch C. Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ. Res. 1988, 62:116-126.
92. Wilde A.A., Postema P.G., Di Diego J.M., Viskin S., Morita H., Fish J.M., et al. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J. Mol. Cell. Cardiol. 2010, 49:543-553.
93. Antzelevitch C., Nof E. Brugada syndrome: recent advances and controversies. Curr. Cardiol. Rep. 2008, 10:376-383.
94. Postema P.G., van Dessel P.F., de Bakker J.M., Dekker L.R., Linnenbank A.C., Hoogendijk M.G., et al. Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study. Circ. Arrhythm. Electrophysiol. 2008, 1:379-386.
95. Benson D.W., Wang D.W., Dyment M., Knilans T.K., Fish F.A., Strieper M.J., et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Investig. 2003, 112:1019-1028.
96. Tan H.L., Bink-Boelkens M.T., Bezzina C.R., Viswanathan P.C., Beaufort-Krol G.C., van Tintelen P.J., et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 2001, 409:1043-1047.
97. Schott J.J., Alshinawi C., Kyndt F., Probst V., Hoorntje T.M., Hulsbeek M., et al. Cardiac conduction defects associate with mutations in SCN5A. Nat. Genet. 1999, 23:20-21.
98. Probst V., Kyndt F., Potet F., Trochu J.N., Mialet G., Demolombe S., et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. J. Am. Coll. Cardiol. 2003, 41:643-652.
99. Royer A., van Veen T.A., Le Bouter S., Marionneau C., Griol-Charhbili V., Leoni A.L., et al. Mouse model of SCN5A-linked hereditary Lenegre's disease: age-related conduction slowing and myocardial fibrosis. Circulation 2005, 111:1738-1746.
100. Remme C.A., Wilde A.A., Bezzina C.R. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc. Med. 2008, 18:78-87.
101. Hothi S.S., Ara F., Timperley J. p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter. J. Cardiovasc. Electrophysiol. 2015, 26:93-97.
102. Liu M., Yang K.C., Dudley S.C. Cardiac sodium channel mutations: why so many phenotypes?. Nat. Rev. Cardiol. 2014, 11:607-615.
103. Gelband H., Bassett A.L. Depressed transmembrane potentials during experimentally induced ventricular failure in cats. Circ. Res. 1973, 32:625-634.
104. Ufret-Vincenty C.A., Baro D.J., Lederer W.J., Rockman H.A., Quinones L.E., Santana L.F. Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. J. Biol. Chem. 2001, 276:28197-28203.
105. Valdivia C.R., Chu W.W., Pu J., Foell J.D., Haworth R.A., Wolff M.R., et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J. Mol. Cell. Cardiol. 2005, 38:475-483.
106. i handling in the failing human heart. Cardiovasc. Res. 2003, 57:874-886.
107. Huang B., El-Sherif T., Gidh-Jain M., Qin D., El-Sherif N. Alterations of sodium channel kinetics and gene expression in the postinfarction remodeled myocardium. J. Cardiovasc. Electrophysiol. 2001, 12:218-225.
108. Moreno J.D., Clancy C.E. Pathophysiology of the cardiac late Na current and its potential as a drug target. J. Mol. Cell. Cardiol. 2012, 52:608-619.
109. 2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1597-H1608.
110. Lou Q., Janardhan A., Efimov I.R. Remodeling of calcium handling in human heart failure. Adv. Exp. Med. Biol. 2012, 740:1145-1174.
111. 2+ leak in heart failure. Circ. Res. 2005, 97:1314-1322.
112. Gross G.J., Auchampach J.A. Role of ATP dependent potassium channels in myocardial ischaemia. Cardiovasc. Res. 1992, 26:1011-1016.
113. + channels in myocardial ischemia. Jpn. Heart J. 1997, 38:297-315.
114. + loss in hypoxic and ischaemic mammalian ventricle. J. Physiol. 1992, 447:649-673.
115. Workman A.J., MacKenzie I., Northover B.J. Do KATP channels open as a prominent and early feature during ischaemia in the Langendorff-perfused rat heart?. Basic Res. Cardiol. 2000, 95:250-260.
116. Fisch C. Relation of electrolyte disturbances to cardiac arrhythmias. Circulation 1973, 47:408-419.
117. +-induced polarization on (dV/dt)max, threshold potential, and membrane input resistance in guinea pig and cat ventricular myocardium. Circ. Res. 1979, 44:800-814.
118. Buchanan J.W., Saito T., Gettes L.S. The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium. Circ. Res. 1985, 56:696-703.
119. + concentration on cable properties and excitability of sheep cardiac Purkinje fibers. Circ. Res. 1970, 26:565-574.
120. Veenstra R.D., Wang H.Z., Beyer E.C., Brink P.R. Selective dye and ionic permeability of gap junction channels formed by connexin45. Circ. Res. 1994, 75:483-490.
121. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
122. Keely S.L. Activation of cAMP-dependent protein kinase without a corresponding increase in phosphorylase activity. Res. Commun. Chem. Pathol. Pharmacol. 1977, 18:283-290.
123. Murphy B.J., Rogers J., Perdichizzi A.P., Colvin A.A., Catterall W.A. cAMP-dependent phosphorylation of two sites in the alpha subunit of the cardiac sodium channel. J. Biol. Chem. 1996, 271:28837-28843.
124. Hallaq H., Yang Z., Viswanathan P.C., Fukuda K., Shen W., Wang D.W., et al. Quantitation of protein kinase A-mediated trafficking of cardiac sodium channels in living cells. Cardiovasc. Res. 2006, 72:250-261.
125. Luo J.H., Weinstein I.B. Calcium-dependent activation of protein kinase C. The role of the C2 domain in divalent cation selectivity. J. Biol. Chem. 1993, 268:23580-23584.
126. + channel inactivation gate is required for modulation by protein kinase C. J. Gen. Physiol. 1996, 108:375-379.
127. Robertson J.D. The occurrence of a subunit pattern in the unit membranes of club endings in Mauthner cell synapses in goldfish brains. J. Cell Biol. 1963, 19:201-221.
128. Spray D.C., Burt J.M. Structure-activity relationships of the cardiac gap junction channel. Am. J. Physiol. 1990, 258:C195-C205.
129. Dhillon P.S., Gray R., Kojodjojo P., Jabr R., Chowdhury R., Fry C.H., et al. Relationship between gap-junctional conductance and conduction velocity in mammalian myocardium. Circ. Arrhythm. Electrophysiol. 2013, 6:1208-1214.
130. Peters N.S. Gap junctions: clarifying the complexities of connexins and conduction. Circ. Res. 2006, 99:1156-1158.
131. Davis L.M., Kanter H.L., Beyer E.C., Saffitz J.E. Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J. Am. Coll. Cardiol. 1994, 24:1124-1132.
132. Beyer E.C., Paul D.L., Goodenough D.A. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J. Cell Biol. 1987, 105:2621-2629.
133. Gourdie R.G., Green C.R., Severs N.J., Anderson R.H., Thompson R.P. Evidence for a distinct gap-junctional phenotype in ventricular conduction tissues of the developing and mature avian heart. Circ. Res. 1993, 72:278-289.
134. Gourdie R.G., Severs N.J., Green C.R., Rothery S., Germroth P., Thompson R.P. The spatial distribution and relative abundance of gap-junctional connexin40 and connexin43 correlate to functional properties of components of the cardiac atrioventricular conduction system. J. Cell Sci. 1993, 105(Pt 4):985-991.
135. Moreno A.P., Saez J.C., Fishman G.I., Spray D.C. Human connexin43 gap junction channels. Regulation of unitary conductances by phosphorylation. Circ. Res. 1994, 74:1050-1057.
136. Beblo D.A., Wang H.Z., Beyer E.C., Westphale E.M., Veenstra R.D. Unique conductance, gating, and selective permeability properties of gap junction channels formed by connexin40. Circ. Res. 1995, 77:813-822.
137. Bukauskas F.F., Verselis V.K. Gap junction channel gating. Biochim. Biophys. Acta 2004, 1662:42-60.
138. Musil L.S., Goodenough D.A. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J. Cell Biol. 1991, 115:1357-1374.
139. Saez J.C., Nairn A.C., Czernik A.J., Fishman G.I., Spray D.C., Hertzberg E.L. Phosphorylation of connexin43 and the regulation of neonatal rat cardiac myocyte gap junctions. J. Mol. Cell. Cardiol. 1997, 29:2131-2145.
140. Kwak B.R., Hermans M.M., De Jonge H.R., Lohmann S.M., Jongsma H.J., Chanson M. Differential regulation of distinct types of gap junction channels by similar phosphorylating conditions. Mol. Biol. Cell 1995, 6:1707-1719.
141. De Mello W.C. Effect of intracellular injection of calcium and strontium on cell communication in heart. J. Physiol. 1975, 250:231-245.
142. Dahl G., Isenberg G. Decoupling of heart muscle cells: correlation with increased cytoplasmic calcium activity and with changes of nexus ultrastructure. J. Membr. Biol. 1980, 53:63-75.
143. 2+. Am. J. Physiol. 1987, 253:C607-C612.
144. 2+]i on nexal membrane resistance. Pflugers Arch. 1987, 409:394-402.
145. Hermans M.M., Kortekaas P., Jongsma H.J., Rook M.B. pH sensitivity of the cardiac gap junction proteins, connexin 45 and 43. Pflugers Arch. 1995, 431:138-140.
146. Morley G.E., Taffet S.M., Delmar M. Intramolecular interactions mediate pH regulation of connexin43 channels. Biophys. J. 1996, 70:1294-1302.
147. Meyer R., Malewicz B., Baumann W.J., Johnson R.G. Increased gap junction assembly between cultured cells upon cholesterol supplementation. J. Cell Sci. 1990, 96(Pt 2):231-238.
148. Meyer R.A., Lampe P.D., Malewicz B., Baumann W.J., Johnson R.G. Enhanced gap junction formation with LDL and apolipoprotein B. Exp. Cell Res. 1991, 196:72-81.
149. Massey K.D., Minnich B.N., Burt J.M. Arachidonic acid and lipoxygenase metabolites uncouple neonatal rat cardiac myocyte pairs. Am. J. Physiol. 1992, 263:C494-C501.
150. Schubert A.L., Schubert W., Spray D.C., Lisanti M.P. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 2002, 41:5754-5764.
151. Bernardini G., Peracchia C., Peracchia L.L. Reversible effects of heptanol on gap junction structure and cell-to-cell electrical coupling. Eur. J. Cell Biol. 1984, 34:307-312.
152. Deleze J., Herve J.C. Effect of several uncouplers of cell-to-cell communication on gap junction morphology in mammalian heart. J. Membr. Biol. 1983, 74:203-215.
153. Bastiaanse E.M., Jongsma H.J., van der Laarse A., Takens-Kwak B.R. Heptanol-induced decrease in cardiac gap junctional conductance is mediated by a decrease in the fluidity of membranous cholesterol-rich domains. J. Membr. Biol. 1993, 136:135-145.
154. Shiroshita-Takeshita A., Sakabe M., Haugan K., Hennan J.K., Nattel S. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation 2007, 115:310-318.
155. Guerra J.M., Everett T.H., Lee K.W., Wilson E., Olgin J.E. Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 2006, 114:110-118.
156. Stroemlund L.W., Jensen C.F., Qvortrup K., Delmar M., Nielsen M.S. Gap junctions - guards of excitability. Biochem. Soc. Trans. 2015, 43:508-512.
157. Agullo-Pascual E., Cerrone M., Delmar M. Arrhythmogenic cardiomyopathy and Brugada syndrome: diseases of the connexome. FEBS Lett. 2014, 588:1322-1330.
158. Agullo-Pascual E., Lin X., Leo-Macias A., Zhang M., Liang F.X., Li Z., et al. Super-resolution imaging reveals that loss of the C-terminus of connexin43 limits microtubule plus-end capture and NaV1.5 localization at the intercalated disc. Cardiovasc. Res. 2014, 104:371-381.
159. van Veen T.A., Stein M., Royer A., Le Quang K., Charpentier F., Colledge W.H., et al. Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation 2005, 112:1927-1935.
160. Kalcheva N., Qu J., Sandeep N., Garcia L., Zhang J., Wang Z., et al. Gap junction remodeling and cardiac arrhythmogenesis in a murine model of oculodentodigital dysplasia. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20512-20516.
161. Gutstein D.E., Morley G.E., Tamaddon H., Vaidya D., Schneider M.D., Chen J., et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ. Res. 2001, 88:333-339.
162. Guerrero P.A., Schuessler R.B., Davis L.M., Beyer E.C., Johnson C.M., Yamada K.A., et al. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J. Clin. Investig. 1997, 99:1991-1998.
163. Stein M., van Veen T.A., Remme C.A., Boulaksil M., Noorman M., van Stuijvenberg L., et al. Combined reduction of intercellular coupling and membrane excitability differentially affects transverse and longitudinal cardiac conduction. Cardiovasc. Res. 2009, 83:52-60.
164. Stein M., van Veen T.A., Hauer R.N., de Bakker J.M., van Rijen H.V. A 50% reduction of excitability but not of intercellular coupling affects conduction velocity restitution and activation delay in the mouse heart. PLoS One 2011, 6.
165. Morley G.E., Vaidya D., Samie F.H., Lo C., Delmar M., Jalife J. Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J. Cardiovasc. Electrophysiol. 1999, 10:1361-1375.
166. Eloff B.C., Lerner D.L., Yamada K.A., Schuessler R.B., Saffitz J.E., Rosenbaum D.S. High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc. Res. 2001, 51:681-690.
167. George S.A., Sciuto K.J., Lin J., Salama M.E., Keener J.P., Gourdie R.G., et al. Extracellular sodium and potassium levels modulate cardiac conduction in mice heterozygous null for the connexin43 gene. Pflugers Arch. 2015.
168. Thomas S.A., Schuessler R.B., Berul C.I., Beardslee M.A., Beyer E.C., Mendelsohn M.E., et al. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation 1998, 97:686-691.
169. van Rijen H.V., Eckardt D., Degen J., Theis M., Ott T., Willecke K., et al. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation 2004, 109:1048-1055.
170. Vaidya D., Tamaddon H.S., Lo C.W., Taffet S.M., Delmar M., Morley G.E., et al. Null mutation of connexin43 causes slow propagation of ventricular activation in the late stages of mouse embryonic development. Circ. Res. 2001, 88:1196-1202.
171. Beauchamp P., Choby C., Desplantez T., de Peyer K., Green K., Yamada K.A., et al. Electrical propagation in synthetic ventricular myocyte strands from germline connexin43 knockout mice. Circ. Res. 2004, 95:170-178.
172. Wiegerinck R.F., van Veen T.A., Belterman C.N., Schumacher C.A., Noorman M., de Bakker J.M., et al. Transmural dispersion of refractoriness and conduction velocity is associated with heterogeneously reduced connexin43 in a rabbit model of heart failure. Heart Rhythm. 2008, 5:1178-1185.
173. Boulaksil M., Winckels S.K., Engelen M.A., Stein M., van Veen T.A., Jansen J.A., et al. Heterogeneous connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias. Eur. J. Heart Fail. 2010, 12:913-921.
174. Kaplan S.R., Gard J.J., Protonotarios N., Tsatsopoulou A., Spiliopoulou C., Anastasakis A., et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 2004, 1:3-11.
175. Wit A.L., Peters N.S. The role of gap junctions in the arrhythmias of ischemia and infarction. Heart Rhythm. 2012, 9:308-311.
176. Toyofuku T., Yabuki M., Otsu K., Kuzuya T., Tada M., Hori M. Functional role of c-Src in gap junctions of the cardiomyopathic heart. Circ. Res. 1999, 85:672-681.
177. Huang X.D., Sandusky G.E., Zipes D.P. Heterogeneous loss of connexin43 protein in ischemic dog hearts. J. Cardiovasc. Electrophysiol. 1999, 10:79-91.
178. Beardslee M.A., Lerner D.L., Tadros P.N., Laing J.G., Beyer E.C., Yamada K.A., et al. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ. Res. 2000, 87:656-662.
179. Smith J.H., Green C.R., Peters N.S., Rothery S., Severs N.J. Altered patterns of gap junction distribution in ischemic heart disease. An immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am. J. Pathol. 1991, 139:801-821.
180. Lampe P.D., TenBroek E.M., Burt J.M., Kurata W.E., Johnson R.G., Lau A.F. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J. Cell Biol. 2000, 149:1503-1512.
181. Tse G., Hothi S.S., Grace A.A., Huang C.L. Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts. J. Physiol. Sci. 2012, 62:79-92.
182. Li G., Whittaker P., Yao M., Kloner R.A., Przyklenk K. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc. Pathol. 2002, 11:158-165.
183. Chen B.P., Mao H.J., Fan F.Y., Bruce I.C., Xia Q. Delayed uncoupling contributes to the protective effect of heptanol against ischaemia in the rat isolated heart. Clin. Exp. Pharmacol. Physiol. 2005, 32:655-662.
184. Fast V.G., Kleber A.G. Block of impulse propagation at an abrupt tissue expansion: evaluation of the critical strand diameter in 2- and 3-dimensional computer models. Cardiovasc. Res. 1995, 30:449-459.
185. Leon L.J., Roberge F.A. Directional characteristics of action potential propagation in cardiac muscle. A model study. Circ. Res. 1991, 69:378-395.
186. Rohr S., Kucera J.P., Fast V.G., Kleber A.G. Paradoxical improvement of impulse conduction in cardiac tissue by partial cellular uncoupling. Science 1997, 275:841-844.
187. Pahor M., Bernabei R., Sgadari A., Gambassi G., Lo Giudice P., Pacifici L., et al. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 1991, 18:148-157.
188. Gay-Jordi G., Guash E., Benito B., Brugada J., Nattel S., Mont L., et al. Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. PLoS One 2013, 8.
189. Sevilla M.A., Voces F., Carron R., Guerrero E.I., Ardanaz N., San Roman L., et al. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal. Life Sci. 2004, 75:881-891.
190. Stein M., Boulaksil M., Jansen J.A., Herold E., Noorman M., Joles J.A., et al. Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H310-H321.
191. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010, 106:1675-1680.
192. Samuel C.S., Unemori E.N., Mookerjee I., Bathgate R.A., Layfield S.L., Mak J., et al. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 2004, 145:4125-4133.
193. Bathgate R.A., Lekgabe E.D., McGuane J.T., Su Y., Pham T., Ferraro T., et al. Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis. Mol. Cell. Endocrinol. 2008, 280:30-38.
194. Coronel R., Casini S., Koopmann T.T., Wilms-Schopman F.J., Verkerk A.O., de Groot J.R., et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005, 112:2769-2777.